Download Analyses of the Regulatory Mechanisms of Tankyrase and Its Role

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

SR protein wikipedia , lookup

Proteasome wikipedia , lookup

Histone acetylation and deacetylation wikipedia , lookup

P-type ATPase wikipedia , lookup

Intrinsically disordered proteins wikipedia , lookup

Signal transduction wikipedia , lookup

SULF1 wikipedia , lookup

JADE1 wikipedia , lookup

Apoptosome wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
Award ID:
RP140661
Project Title:
Analyses of the Regulatory Mechanisms of Tankyrase and Its Role in
Tumorigenesis
Award Mechanism:
Individual Investigator
Principal Investigator:
Zhang, Xuewu
Entity:
The University of Texas Southwestern Medical Center
Lay Summary:
Tankyrases are members of a group of enzymes called PARPs, which modify their target
proteins by adding one or a polymer chain of the ADP-ribose group. This modification
regulates various aspects of many proteins, including their biological activity and
destruction. Through this modification, tankyrase controls several important cellular
processes such as cell proliferation and telomere homeostasis. Dysregulation of these
processes is often associated with cancer. Therefore, inhibition of tankyrases by small
molecule inhibitors is a promising strategy for targeted cancer therapy. However, side
effects of current inhibitors of tankyrases, due mainly to off-target inhibition of other
PARP family proteins, hinder their application in clinic. Besides the catalytic domain,
tankyrases possess multiple additional domains that are functionally important. These
additional domains endow unique regulatory mechanisms that distinguish tankyrases
from other PARPs. These mechanisms are poorly understood at present. Through
determining the crystal structure of tankyrase’s catalytic domain bound to its inhibitor,
we have uncovered a potentially novel regulatory mechanism controlling tankyrase
activity through conformational changes in its catalytic domain. Furthermore, we have
identified an endogenous inhibitor of tankyrases that is specifically expressed in cancer
cells, suggesting that tankyrase activity is deregulated in cancer. This proposal will
examine these hypotheses. This study will lead to a better understanding of the unique
regulatory mechanisms of tankyrases and ultimately facilitate development of novel anticancer therapeutics.